| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 773.00K | — |
| Operating expense | — | — |
| Net income | -39.70M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, UPB returned -60.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -74.3% |
| 1 year | -60.5% |
| All-time high | $31.08 (Jan 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in UPB would be worth today ›No. Upstream Bio, Inc. has not paid a dividend in the past 12 months.
Upstream Bio, Inc. stock trades on NASDAQ under the ticker symbol UPB.
Upstream Bio, Inc. is part of the Healthcare sector.
Upstream Bio, Inc. has a market cap of 381.75M USD, based on the latest quote.
Upstream Bio, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
